The Potential for Ion Mobility in Pharmaceutical and Clinical Analyses

Area of Science:

• Analytical Chemistry
• Biotechnology
• Clinical Diagnostics

Background:

• Accurate, high-throughput analyses are crucial for global health, driven by the pharmaceutical and clinical industries.
• Liquid chromatography-tandem mass spectrometry (LC-MS) has improved analytical capabilities but has limitations.
• Further advancements are needed to enhance analytical performance in these critical sectors.

Purpose of the Study:

• To explore the potential of ion mobility technology to improve analytical methods in the pharmaceutical and clinical industries.
• To highlight ion mobility's capacity for isomer separation and increased throughput.
• To discuss the application of ion mobility in glycosylation monitoring of biologics and vitamin D analysis.

Main Methods:

• Review of ion mobility principles and its integration with existing analytical platforms.
• Case study 1: Application in monitoring glycosylation of biological drugs.
• Case study 2: Application in vitamin D analysis for clinical diagnostics.

Main Results:

• Ion mobility offers enhanced data sets through isomer separation, improving analytical specificity.
• Potential for significantly increased sample throughput, with separations as fast as 60 ms.
• Demonstrated applicability in complex analyses relevant to both pharmaceutical and clinical settings.

Conclusions:

• Ion mobility technology presents a significant opportunity to advance pharmaceutical and clinical analyses.
• Successful adoption requires addressing current implementation hurdles in both fields.
• This technology promises more comprehensive and efficient analytical outcomes for critical health applications.